Barclays PLC acquired a new position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 1,533,765 shares of the real estate investment trust's stock, valued at approximately $35,078,000. Barclays PLC owned about 0.22% of Healthpeak Properties at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the company. State Street Corp bought a new position in Healthpeak Properties in the third quarter valued at approximately $1,093,576,000. Charles Schwab Investment Management Inc. acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $175,697,000. Sumitomo Mitsui Trust Group Inc. bought a new position in shares of Healthpeak Properties in the 3rd quarter worth $102,615,000. Finally, Heitman Real Estate Securities LLC acquired a new stake in shares of Healthpeak Properties during the third quarter worth $69,118,000. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Stock Performance
NYSE DOC traded down $0.17 during trading on Friday, reaching $20.76. 7,231,713 shares of the company's stock were exchanged, compared to its average volume of 5,650,051. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The business has a 50 day moving average price of $21.94 and a 200-day moving average price of $21.36. The stock has a market capitalization of $14.52 billion, a P/E ratio of 44.17, a PEG ratio of 2.37 and a beta of 1.13. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business had revenue of $700.40 million for the quarter, compared to the consensus estimate of $682.51 million. During the same quarter in the prior year, the firm posted $0.45 earnings per share. The business's revenue was up 25.9% compared to the same quarter last year. Sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.78%. The ex-dividend date was Monday, November 4th. Healthpeak Properties's dividend payout ratio is presently 255.32%.
Wall Street Analyst Weigh In
DOC has been the subject of several analyst reports. Evercore ISI boosted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an "outperform" rating in a research report on Monday, September 16th. Mizuho cut their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. Royal Bank of Canada boosted their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a report on Monday, November 4th. StockNews.com downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday, October 30th. Finally, Citigroup boosted their target price on Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a research note on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $22.93.
Check Out Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.